Persephone Biosciences crafts microbial drugs to fight cancer using AI and gut microbiome analysis.
Tolerion: A bio-therapeutic company engineering solutions for autoimmune diseases since 2001.
Angiex, a world-class biotherapeutics company, specializes in vascular-targeted treatments focusing on angiogenesis.
Rani Therapeutics in San Jose develops innovative oral biologics for various medical conditions.
Virvio: Developing a shelf-stable, single-dose biotherapeutic for global influenza containment.
GentiBio, Inc.: Pioneering biotherapeutics with engineered T cells to treat immune and allergic diseases.
BHS, a Carnegie Mellon spin-off, pioneers next-gen protein-polymer biotherapeutics from Pittsburgh, US.
Los Angeles-based medical organization specializing in pre-clinical bio-therapeutics.
Ventrix Inc., a San Diego-based company, develops VentriGel, a hydrogel innovation for cardiac tissue repair, providing a restorative scaffold for new cell growth.
SanaRx Biotherapeutics: Advancing detection and treatment for rare diseases, aiming for FDA approval.
SciBac develops biotherapeutics using patented technology to treat chronic infections, focusing on cystic fibrosis.
Fzata, a noble biotech firm, pioneers in oral biologics and gastrointestinal drug development using BioPYM technology.
Lassen Therapeutics: Innovating best-in-class biotherapeutics for serious diseases.
BioPlx, an advanced microbiome company, develops non-antibiotic solutions to control infectious diseases using live bio-therapeutic products.
Valerion Therapeutics develops bio-therapeutics using a proprietary technology for disease treatment.
Revolo Biotherapeutics develops superior, long-term disease remission therapies with less frequent dosing.
Siolta Therapeutics: A venture-backed biotech firm innovating in inflammatory disease prevention.
aTyr Pharma, a US-based public biotherapeutics company, specializes in researching tRNA synthetases.
Mulberry Biotherapeutics: Innovating targeted therapies for rare genetic disorders like NF2.
Alveolus Bio: Innovating FDA-approved therapeutics for lung diseases.
Q32 Bio is a biotech firm developing therapies to balance the immune system in severe autoimmune diseases.
SalubrisBio, a subsidiary of Salubris Pharmaceuticals, is a China-based biotech firm specializing in innovative R&D.
Ceramedix Holding, a NYC-based medical firm, develops antibody-based drugs for novel diseases.
Plakous Therapeutics: Pioneering regenerative healing with human placenta-derived cytokines and growth factors.
Gusto Global develops live biotherapeutic products targeting inflammatory bowel disease and cancer.